Suppr超能文献

[单克隆丙种球蛋白血症中最小髓质浆细胞增多症的解读。半薄切片骨髓活检及免疫标记研究的重要性]

[Interpretation of minimal medullary plasmacytoses in monoclonal dysglobulinemias. Importance of the study of osteomedullary biopsies of semi-thin sections and immunologic marking].

作者信息

Canioni D, Kermarec J

出版信息

Ann Pathol. 1982;2(4):279-92.

PMID:6760876
Abstract

A monoclonal gammopathy (M.G.) is usually associated with multiple myeloma or macroglobulinemia. Cases whose follow up have not demonstrated myeloma or lymphoma for several years are called "benign monoclonal gammopathies" (B.M.G.). Numerous criteria were suggested to distinguish multiple myeloma from B.M.G., chiefly an abnormal medullary plasmacytosis. But frequently it is only beyond 15 to 20 % that this plasmacytosis is considered as significative. Some authors have reported the peculiarities of these plasma cells immune labelling with rather conflicting results. We reviewed semi-thin sections of bone marrow biopsies with a low grade plasmacytosis (less than or equal to 10 %) by histological cytological and immunological methods in a group of 39 patients with a M.G. A diagnosis of multiple myeloma or of B.M.G. was made on the initial examination of these biopsies. The 24 cases of multiple myeloma were diagnosed using : --topographical criteria : inhomogenous sharing, nests of plasmocytes exclusively away from the periphery of vessels, --cytological criteria such as frequent cellular immaturity, nuclear immaturity in binucleated cells, bizarre shaped nuclei . . . --immunological criteria obtained by immunofluorescence method : strictly monoclonal labelling of plasma cells or "limit"-monoclonal labelling in 50 % of cases. The latter is less characteristic because of its presence in 25 % of B.M.G. In this prospective study, the initial diagnosis was maintained in 37 out of the 39 cases according to clinical and laboratory data. These results seem to demonstrate the practical value of the proposed criteria.

摘要

单克隆丙种球蛋白病(M.G.)通常与多发性骨髓瘤或巨球蛋白血症相关。随访数年未显示骨髓瘤或淋巴瘤的病例被称为“良性单克隆丙种球蛋白病”(B.M.G.)。人们提出了许多标准来区分多发性骨髓瘤和B.M.G.,主要是异常的骨髓浆细胞增多。但通常只有当这种浆细胞增多超过15%至20%时才被认为具有意义。一些作者报告了这些浆细胞免疫标记的特点,结果相当矛盾。我们用组织学、细胞学和免疫学方法对39例M.G.患者的骨髓活检半薄切片进行了回顾,这些切片显示为低度浆细胞增多(小于或等于10%)。在对这些活检进行初步检查时做出了多发性骨髓瘤或B.M.G.的诊断。24例多发性骨髓瘤的诊断采用了:——拓扑学标准:分布不均匀,浆细胞巢仅远离血管周边;——细胞学标准,如细胞频繁不成熟、双核细胞中的核不成熟、核形状怪异……——通过免疫荧光法获得的免疫学标准:浆细胞严格单克隆标记或50%的病例为“界限”单克隆标记。后者的特征性较差,因为在25%的B.M.G.中也有出现。在这项前瞻性研究中,根据临床和实验室数据,39例中的37例维持了初步诊断。这些结果似乎证明了所提出标准的实用价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验